BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 2961628)

  • 1. Retinoids in disorders of keratinization: their use in adults.
    Happle R; van de Kerkhof PC; Traupe H
    Dermatologica; 1987; 175 Suppl 1():107-24. PubMed ID: 2961628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acitretin in the treatment of severe disorders of keratinization. Results of an open study.
    Blanchet-Bardon C; Nazzaro V; Rognin C; Geiger JM; Puissant A
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):982-6. PubMed ID: 1831211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An appraisal of acitretin therapy in children with inherited disorders of keratinization.
    Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI
    Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoids in keratinizing diseases and acne.
    Ruiz-Maldonado R; Tamayo L
    Pediatr Clin North Am; 1983 Aug; 30(4):721-34. PubMed ID: 6193480
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral retinoid (Ro 10-9359) in children with lamellar ichthyosis, epidermolytic hyperkeratosis and symmetrical progressive erythrokeratoderma.
    Tamayo L; Ruiz-Maldonado R
    Dermatologica; 1980; 161(5):305-14. PubMed ID: 6449393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
    Kragballe K; Steijlen PM; Ibsen HH; van de Kerkhof PC; Esmann J; Sorensen LH; Axelsen MB
    Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillon-Lefèvre syndrome. Successful treatment with oral retinoids in three patients.
    el Darouti MA; Al Raubaie SM; Eiada MA
    Int J Dermatol; 1988; 27(1):63-6. PubMed ID: 2964426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow-cytometric investigation of epidermal cell characteristics in monogenic disorders of keratinization and their modulation by topical calcipotriol treatment.
    Lucker GP; Steijen PM; Suykerbuyk EJ; Kragballe K; Brandrup F; van de Kerkhof PC
    Acta Derm Venereol; 1996 Mar; 76(2):97-101. PubMed ID: 8740259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical investigation of acitretin in children with severe inherited keratinization disorders in China.
    Zhang XB; Luo Q; Li CX; He YQ; Xu X
    J Dermatolog Treat; 2008; 19(4):221-8. PubMed ID: 18608715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etretinate therapy in children with severe keratinization defects.
    Traupe H; Happle R
    Eur J Pediatr; 1985 Jan; 143(3):166-9. PubMed ID: 2580708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids in psoriasis and disorders of keratinization.
    Fritsch PO
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S8-14. PubMed ID: 1460124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients.
    Katugampola RP; Finlay AY
    Br J Dermatol; 2006 Feb; 154(2):267-76. PubMed ID: 16433796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic use of an aromatic derivative of vitamin A acid (Ro 10-9359) in psoriasis and keratosis].
    Schimpf A
    Z Hautkr; 1976 Apr; 51(7):265-75. PubMed ID: 134523
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe disorders of keratinization: effects of treatment with Tigason (etretinate).
    Marks R; Finlay AY; Holt PJ
    Br J Dermatol; 1981 Jun; 104(6):667-73. PubMed ID: 7248177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral retinoid (Tigason R etretinate) therapy in congenital disorders of keratinisation.
    Rajan VS; Thirumoorthy T
    Ann Acad Med Singap; 1983 Jan; 12(1):45-51. PubMed ID: 6222685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal.
    Findlay GH
    S Afr Med J; 1983 Jul; 64(2):54-6. PubMed ID: 6867876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acitretin therapy in keratinization disorders].
    van Dooren-Greebe RJ; van de Kerkhof PC; Steijlen PM; Happle R
    Ned Tijdschr Geneeskd; 1990 Oct; 134(41):1995-2000. PubMed ID: 2146515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral treatment of lamellar ichthyosis (non-bullous congenital ichthyosiform erythroderma) with an aromatic retinoid (author's transl)].
    Frenk E
    Dermatologica; 1981; 162(2):91-103. PubMed ID: 7018943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Keratosis palmaris et plantaris areata Siemens. Therapeutic experiments with aromatic retinoid Ro 10-9359].
    Luderschmidt C; Plewig G
    Hautarzt; 1980 Feb; 31(2):96-9. PubMed ID: 6447125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term oral treatment of two pronounced ichthyotic conditions: lamellar ichthyosis and epidermolytic hyperkeratosis with the aromatic retinoid, Tigason (RO 10-9359).
    El-Ramly M; Zachariae H
    Acta Derm Venereol; 1983; 63(5):452-6. PubMed ID: 6197852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.